Article thumbnail

Genetic Risk Score Predicting Risk of Rheumatoid Arthritis Phenotypes and Age of Symptom Onset

By Lori B. Chibnik, Brendan T. Keenan, Jing Cui, Katherine P. Liao, Karen H. Costenbader, Robert M. Plenge and Elizabeth W. Karlson
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1983). A clinical study of older age rheumatoid arthritis with comparison to a younger onset group.
  2. (2004). A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.
  3. (1980). A screening strategy for population studies in systemic lupus erythematosus. Series design.
  4. (2003). Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
  5. (2007). Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis.
  6. (2007). Association of arthritis with a gene complex encoding C-type lectin-like receptors.
  7. (2005). Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.
  8. (2008). Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.
  9. (2009). Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies.
  10. (2008). Common variants at CD40 and other loci confer risk of rheumatoid arthritis.
  11. (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.
  12. (2010). Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk.
  13. (2010). Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk. Ann Rheum Dis;in press.
  14. (2008). Defining the role of the MHC in autoimmunity: a review and pooled analysis.
  15. (2005). Demonstrating stratification in a European American population.
  16. (2009). Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region.
  17. (1999). Does the age of onset of rheumatoid arthritis influence phenotype?: a prospective study of outcome and prognostic factors. Rheumatology (Oxford)
  18. (1989). DR4 prevalence related to the age at disease onset in female patients with rheumatoid arthritis.
  19. (2000). Elderly onset rheumatoid arthritis: clinical aspects.
  20. (1998). Elderlyonset rheumatoid arthritis and its association with HLA-DRB1 alleles in Japanese.
  21. (2010). Genetic basis of autoantibody positive and negative rheumatoid arthritis risk in a multi-ethnic cohort derived from electronic health records.
  22. (2008). Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking.
  23. (2004). Genetic signatures of strong recent positive selection at the lactase gene.
  24. (2009). Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk.
  25. (2010). Genomewide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nature Genetics;in press.
  26. (1986). HLA and rheumatoid arthritis: a combined analysis of 440 British patients.
  27. (1995). IgM, IgA, and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression?
  28. (2007). Increasing age at symptom onset is associated with worse radiological damage at presentation in patients with early inflammatory polyarthritis.
  29. (2009). Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score.
  30. (2001). Links between radiological change, disability, and pathology in rheumatoid arthritis.
  31. (2006). Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis.
  32. (2005). Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression.
  33. (2001). Markers for work disability in rheumatoid arthritis.
  34. (2003). Metaanalysis of genetic association studies supports a contribution of common variants to susceptibility to common disease.
  35. (1991). Older versus younger onset rheumatoid arthritis: results at onset and after 2 years of a prospective followup study of early rheumatoid arthritis.
  36. (2009). Opposing effects of HLA-DRB1*13 alleles on the risk of developing anticitrullinated protein antibody-positive and anti-citrullinated protein antibodynegative rheumatoid arthritis.
  37. (2004). Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis.
  38. (2001). Predictors of radiographic joint damage in patients with early rheumatoid arthritis.
  39. (1985). Prognostic factors and diagnostic criteria in early rheumatoid arthritis.
  40. (2006). Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment.
  41. (2003). Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases.
  42. (2001). Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.
  43. (2005). Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.
  44. (2001). Rheumatoid arthritis.
  45. (2009). Rheumatoid arthritis. Lancet 373: 659–672. Genetic Risk Score Predicting
  46. (2004). Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations.
  47. (2002). Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort.
  48. (2003). Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients.
  49. Saag KG (2001) Comorbidity in rheumatoid arthritis.
  50. (2006). Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women.
  51. (2010). Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis.
  52. (2007). STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus.
  53. (2006). The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.
  54. (1983). The prediction of radiological destruction during the early stage of rheumatoid arthritis.
  55. (2009). The value of HLA-DRB1 shared epitope, 2308 tumor necrosis factor-alpha gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis.
  56. (2007). TRAF1-C5 as a risk locus for rheumatoid arthritis–a genomewide study.
  57. (2007). Two independent alleles at 6q23 associated with risk of rheumatoid arthritis.